<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01580358</url>
  </required_header>
  <id_info>
    <org_study_id>CCMP98 -CT-203</org_study_id>
    <nct_id>NCT01580358</nct_id>
  </id_info>
  <brief_title>Therapeutic Effects of Traditional Chinese Medicine, Shen-Mai San in Cancer Patient Undergoing Chemotherapy or Radiotherapy</brief_title>
  <official_title>Changhua Christian Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhua Christian Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Committee on Chinese Medicine and Pharmacy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Changhua Christian Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using Shen-Mai-San for cancer patients undergoing chemotherapy or radiotherapy could help
      these people improve the quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Shen-Mai-San could improve fatigue, general weakness, neutropenia for patients under going
      chemotherapy or radiotherapy.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2009</start_date>
  <completion_date type="Anticipated">September 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in EORTC QOL-C30 at four weeks</measure>
    <time_frame>baseline and four weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in BUN, Creatinine, GOT, GPT at four weeks</measure>
    <time_frame>baseline and four weeks</time_frame>
    <description>monitor the liver function and renal function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Heart rate variability at four weeks</measure>
    <time_frame>baseline and four weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cancer Patients Undergoing Chemotherapy or Radiotherapy</condition>
  <arm_group>
    <arm_group_label>Shen-Mai San</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Shen mai san is composed of three herb medicines, Ginseng radis, Liriope spicata, and Schizandrae fructus and was manufactured into concentrated herbal extract and packed with 0.5g per capsule and labeled by Sun-Ten pharmaceutical company in Taiwan with good manufacturing practice (GMP).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>starch</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Starch in the same granule as intervention group for this double-blind trial</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Shen-Mai San</intervention_name>
    <description>Shen mai san is composed of three herb medicines, Ginseng radis, Liriope spicata, and Schizandrae fructus and was manufactured into concentrated herbal extract and packed with 0.5g per capsule and labeled by Sun-Ten pharmaceutical company in Taiwan with good manufacturing practice (GMP).</description>
    <arm_group_label>Shen-Mai San</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Starch</intervention_name>
    <description>It was packed in granules with 0.5gm starch. Patients took eight granules three times per day for four weeks.</description>
    <arm_group_label>starch</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Postoperative patients with histologically confirmed cancer within 3 years and
             undergoing chemotherapy or radiotherapy

          -  age above 18 years old

          -  signed informed consent

          -  ability to read Chinese, ability for oral intake.

        Exclusion Criteria:

          -  being pregnancy

          -  on breast feeding

          -  completed chemotherapy or radiotherapy

          -  brain metastasis with Eastern Cooperative Oncology Group (ECOG) performance status of
             two to four

          -  delusion or hallucination

          -  acute infection

          -  received medications for other clinical trials.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lun Chien Lo, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Changhua Christian Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chia Yun Chen, MD</last_name>
    <phone>+886-47238595</phone>
    <phone_ext>4027</phone_ext>
    <email>137877@cch.org.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Changhua Christian Hospital</name>
      <address>
        <city>Changhua</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chia Yun Chen, MD</last_name>
      <phone>+886-47238595</phone>
      <phone_ext>4027</phone_ext>
      <email>137877@cch.org.tw</email>
    </contact>
    <investigator>
      <last_name>Lun Chien Lo, MD.PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2012</study_first_submitted>
  <study_first_submitted_qc>April 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 19, 2012</study_first_posted>
  <last_update_submitted>June 19, 2012</last_update_submitted>
  <last_update_submitted_qc>June 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 21, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhua Christian Hospital</investigator_affiliation>
    <investigator_full_name>Chia-Yun Chen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>cancer</keyword>
  <keyword>radiotherapy</keyword>
  <keyword>chemotherapy</keyword>
  <keyword>Traditional Chinese Medicine</keyword>
  <keyword>Safety</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

